Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects.
Johanna M Ascher BartlettGeorge YanniYong KwonJuliet A EmamaulleePublished in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2022)
This review aims to synthesize the most updated research, outcomes, and trends in the field of pediatric liver transplantation (LT), specifically focusing on children who have suffered from acute liver failure. Pediatric acute liver failure is a dynamic, life-threatening condition that can either self-resolve or lead to death. LT is a lifesaving intervention. With the introduction of technical variant grafts and recent immunosuppression modifications, overall patient survival, graft survival, and waitlist mortality have improved. Furthermore, recent advances in the knowledge of immunologic mediators of acute liver failure offer the possibility of more detailed understanding of the pathophysiology and new areas for research. Given the success of living donor LT for pediatric patients with acute liver failure, this option should continue to be actively considered as an alternative treatment option for patients who are listed for transplantation and are managed at a multidisciplinary tertiary care transplant center.
Keyphrases
- liver failure
- hepatitis b virus
- tertiary care
- randomized controlled trial
- end stage renal disease
- healthcare
- chronic kidney disease
- ejection fraction
- cardiovascular disease
- prognostic factors
- newly diagnosed
- metabolic syndrome
- cardiovascular events
- case report
- skeletal muscle
- free survival
- adipose tissue
- bone marrow
- coronary artery disease
- insulin resistance
- smoking cessation